Pharmacoeconomic evaluation of Pharmacist led diabetes education intervention in Type 2 diabetes patients Randomized Clinical Trial.
Not Applicable
- Conditions
- Diabetes Type 2Metabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12622000658718
- Lead Sponsor
- Muhammad Daoud Butt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 326
Inclusion Criteria
Individuals aging 20 years and above, with a confirmed diagnosis of T2DM and ability to read and write Urdu (the official language of Pakistan) were incorporated in the study.
Exclusion Criteria
Pregnant women, patients with type I diabetes mellitus, having severe diabetic complications, psychiatric disorder and immigrants from other countries
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the overall out-of-pocket cost incurred by the patient evaluated from patient past medical history.[baseline, 26 weeks post-commencement of intervention and 52 weeks post-commencement of intervention, ];Serum HbA1c[baseline, 26 weeks post-commencement of intervention and 52 weeks post-commencement of intervention, ]
- Secondary Outcome Measures
Name Time Method Quality of life assessed with WHOQOL[baseline, 26 weeks post-commencement of intervention and 52 weeks post-commencement of intervention, ];Quality-Adjusted Life Years will be assessed using the patient's past medical record and adjusted quality of life.[baseline and 52 weeks post-commencement of intervention, ];Change in Diabetes Knowledge using a validated 14-item Michigan Diabetes Knowledge Test questionnaire.[Baseline, 26 weeks post-commencement of intervention, 52 weeks post-commencement of intervention];Change in Body Mass Index (BMI) for BMI assessment will be done using height measured with a stadiometer and weight measured with digital scales',[Baseline and 52 weeks post-commencement of intervention,]